Ryan Vargo

Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial

Randolph P. Matthews, Munjal Patel, Stephanie E. Barrett et al. · Nature Medicine · 2021 · 69 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group

Ryan J. Beechinor, Patrick A. Thompson, Michael F. Hwang et al. · Clinical Pharmacokinetics · 2019 · 39 citations · Full text

Pharmacy, Pediatrics, Pharmacokinetics +17

Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV

Randolph P. Matthews, Deanne Jackson Rudd, Saijuan Zhang et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 31 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection

Randolph P. Matthews, Xiaowei Zang, Stephanie E. Barrett et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2022 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-d-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease

W. Joseph Herring, Christopher Assaid, Kerry Budd et al. · Clinical Neuropharmacology · 2017 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +15